The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease

发表于 2026-9-16 15:38:59

期刊：Journal of Clinical Oncology

文献作者：Natasha B. Hunter; Heather A. Parsons; Leslie Cope; Jenna V. Canzoniero; Fabio C.P. Navarro; Sherif El-Refai; Jesus D. Anampa; Joseph A. Sparano; Mothaffar Rimawi; Anna Maria Storniolo; Candace Mainor; Rita Nanda; Angela DeMichele; Gaorav P. Gupta; Erica J. Stringer-Reasor; Filipa Lynce; Erin F. Cobain; Shannon Puhalla; Rachel Jankowitz; Brent Rexer; Ingrid Mayer; E. Shelley Hwang; Kimberly Blackwell; Walid El Ayass; Young Lee; Carol Tweed; Mary Wilkinson; Angela Pennisi; Bonnie Sun; Pamela Wright; Julie R. Gralow; Richard Chen; Sean M. Boyle; Vered Stearns; Antonio C. Wolff; Ben Ho Park

出版日期：2026-5-10

DOI号：10.1200/jco-25-02934

下载链接：https://ascopubs.org/doi/pdfdirect/10.1200/JCO-25-02934

文献链接：https://doi.org/10.1200/jco-25-02934

当前文献来源于 American Society of Clinical Oncology (ASCO)。

备注信息：

发表于 2026-9-16 15:39:00

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[ASCO] The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[ASCO] The Pathologic Response Evaluation and Detection in Circulating Tumor-DNA Study: Ultrasensitive Circulating Tumor-DNA Assessment of Breast Cancer Minimal Residual Disease 一键复制